{"id":2160,"date":"2009-05-12T00:00:00","date_gmt":"2009-05-12T00:00:00","guid":{"rendered":"http:\/\/fefac.cat\/empresarial\/?p=2160"},"modified":"2019-05-30T09:37:41","modified_gmt":"2019-05-30T07:37:41","slug":"la-fefac-considera-el-farmacutic-capacitat-per-in","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/","title":{"rendered":"La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital"},"content":{"rendered":"<div style=\"text-align: justify;\"><b><span style=\"font-size: 11pt;\">Barcelona, <\/span><\/b><b><span style=\"font-size: 11pt;\">12 de maig de 2009.<\/span><\/b><span style=\"font-size: 11pt;\"> Respecte la mesura anunciada ahir per la ministra de Sanitat i Pol\u00edtica Social, Trinidad Jim\u00e9nez, sobre la lliure dispensaci\u00f3 de la p\u00edndola postcoital a les oficines de farm\u00e0cia, la Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) considera que el farmac\u00e8utic, com a professional sanitari amb m\u00e9s \u00e0mplia formaci\u00f3 i experi\u00e8ncia sobre qualsevol tipus de medicament, est\u00e0 perfectament capacitat per informar i assessorar sobre la p\u00edndola postcoital (levonorgestrel). <\/span><\/div>\n<div style=\"text-align: justify;\"><\/div>\n<div style=\"text-align: justify;\"><span style=\"font-size: 11pt;\">L\u2019empresarial de les farm\u00e0cies catalanes creu que el farmac\u00e8utic far\u00e0 una important contribuci\u00f3 a l\u2019\u00fas racional d\u2019aquest f\u00e0rmac, gr\u00e0cies, d\u2019una banda, als seus coneixements sobre els aspectes farmacol\u00f2gics de levonorgestrel, que van des de la dosificaci\u00f3 del f\u00e0rmac fins als seus efectes secundaris, i d\u2019altra banda, gr\u00e0cies a la seva experi\u00e8ncia en la participaci\u00f3 a nombroses campanyes d\u2019informaci\u00f3 i educaci\u00f3 en la prevenci\u00f3 i promoci\u00f3 de la salut, inclosa la sexual. <\/span><\/div>\n<div style=\"text-align: justify;\"><\/div>\n<div style=\"text-align: justify;\"><span style=\"font-size: 11pt;\">D\u2019altra banda, la FEFAC celebra la decisi\u00f3 del Ministeri de Sanitat de permetre la dispensaci\u00f3 sense necessitat de recepta de levonorgestrel en el sentit que demostra que l\u2019Administraci\u00f3 confia en elfarmac\u00e8utic com a agent de salut integrat a la xarxa sanit\u00e0ria. I com a professional de la salut que vetlla pel bon \u00fas dels f\u00e0rmacs, l\u2019empresarial recolza que el farmac\u00e8utic basi les seves actuacions en protocols d\u2019Atenci\u00f3 Farmac\u00e8utica, que en el cas de la p\u00edndola postcoital es fan especialment necessaris.\u00a0<\/span><\/div>\n<div style=\"text-align: justify;\"><\/div>\n<div style=\"text-align: justify;\"><span style=\"font-size: 11pt;\">Respecte si el farmac\u00e8utic t\u00e9 el dret de negar-se o no a dispensar la p\u00edndola postcoital, la FEFAC considera que, com a empresarial, no li correspon de tenir un posicionament institucional en q\u00fcestions que afecten la ideologia individual dels seus associats. No obstant aix\u00f2, defensa la llibertat del farmac\u00e8utic, dins de la seva professionalitat, i opina que, per tal d\u2019evitar conflictes \u00e8tico-morals, caldria comptar amb una regulaci\u00f3 expl\u00edcita del dret d\u2019objecci\u00f3 de consci\u00e8ncia del personal sanitari (inclosos farmac\u00e8utics, metges i infermeres), que en aquests moments no existeix.<\/span><\/div>\n<div style=\"text-align: justify;\"><\/div>\n<div style=\"text-align: justify;\"><span style=\"font-size: 11pt;\">La FEFAC \u00e9s l\u2019organitzaci\u00f3 empresarial que integra les quatre associacions provincials de farm\u00e0cies de Catalunya (Associaci\u00f3 de Farm\u00e0cies de Barcelona, AFB; Associaci\u00f3 de Farm\u00e0cies de Girona, AGFE; Associaci\u00f3 de Farm\u00e0cies de Tarragona, AFET; i Associaci\u00f3 de Farm\u00e0cies de Lleida, AFELL). La FEFAC representa a 1.700 farm\u00e0cies, que suposen aproximadament el 60% de farm\u00e0cies catalanes.<\/span><\/div>\n<div><\/div>\n<div><span style=\"font-size: 11pt;\">____________________<\/span><\/div>\n<div><\/div>\n<div><span style=\"font-size: 11pt;\">Luc\u00eda Gallardo<\/span><\/div>\n<div><span style=\"font-size: 11pt;\">FEFAC<\/span><\/div>\n<div><span style=\"font-size: 11pt;\"><span style=\"font-size: 11pt;\">Responsable de Comunicaci\u00f3<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Barcelona, 12 de maig de 2009. Respecte la mesura anunciada ahir per la ministra de Sanitat i Pol\u00edtica Social, Trinidad Jim\u00e9nez, sobre la lliure dispensaci\u00f3 de la p\u00edndola postcoital a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2067,18,11,12,13,14,15,101],"tags":[70],"class_list":["post-2160","post","type-post","status-publish","format-standard","hentry","category-notes-premsa","category-general","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-sanitaria","tag-pindola-postcoital"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital - FEFAC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital - FEFAC\" \/>\n<meta property=\"og:description\" content=\"Barcelona, 12 de maig de 2009. Respecte la mesura anunciada ahir per la ministra de Sanitat i Pol\u00edtica Social, Trinidad Jim\u00e9nez, sobre la lliure dispensaci\u00f3 de la p\u00edndola postcoital a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2009-05-12T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-30T07:37:41+00:00\" \/>\n<meta name=\"author\" content=\"qabh859\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"qabh859\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-fefac-considera-el-farmacutic-capacitat-per-in\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-fefac-considera-el-farmacutic-capacitat-per-in\\\/\"},\"author\":{\"name\":\"qabh859\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"headline\":\"La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital\",\"datePublished\":\"2009-05-12T00:00:00+00:00\",\"dateModified\":\"2019-05-30T07:37:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-fefac-considera-el-farmacutic-capacitat-per-in\\\/\"},\"wordCount\":435,\"keywords\":[\"p\u00edndola postcoital\"],\"articleSection\":[\"Notes de premsa\",\"General\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"Sanit\u00e0ria\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-fefac-considera-el-farmacutic-capacitat-per-in\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-fefac-considera-el-farmacutic-capacitat-per-in\\\/\",\"name\":\"La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital - FEFAC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"datePublished\":\"2009-05-12T00:00:00+00:00\",\"dateModified\":\"2019-05-30T07:37:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-fefac-considera-el-farmacutic-capacitat-per-in\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-fefac-considera-el-farmacutic-capacitat-per-in\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/la-fefac-considera-el-farmacutic-capacitat-per-in\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\",\"name\":\"qabh859\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/qabh859\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital - FEFAC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/","og_locale":"ca_ES","og_type":"article","og_title":"La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital - FEFAC","og_description":"Barcelona, 12 de maig de 2009. Respecte la mesura anunciada ahir per la ministra de Sanitat i Pol\u00edtica Social, Trinidad Jim\u00e9nez, sobre la lliure dispensaci\u00f3 de la p\u00edndola postcoital a [&hellip;]","og_url":"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/","og_site_name":"FEFAC","article_published_time":"2009-05-12T00:00:00+00:00","article_modified_time":"2019-05-30T07:37:41+00:00","author":"qabh859","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"qabh859","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/"},"author":{"name":"qabh859","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"headline":"La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital","datePublished":"2009-05-12T00:00:00+00:00","dateModified":"2019-05-30T07:37:41+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/"},"wordCount":435,"keywords":["p\u00edndola postcoital"],"articleSection":["Notes de premsa","General","FEFAC","AFB","AFET","AFELL","AGFE","Sanit\u00e0ria"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/","url":"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/","name":"La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital - FEFAC","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"datePublished":"2009-05-12T00:00:00+00:00","dateModified":"2019-05-30T07:37:41+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/la-fefac-considera-el-farmacutic-capacitat-per-in\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"La FEFAC considera el farmac\u00e8utic capacitat per informar i assessorar sobre la p\u00edndola postcoital"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7","name":"qabh859","url":"https:\/\/fefac.cat\/empresarial\/author\/qabh859\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/2160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=2160"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/2160\/revisions"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=2160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=2160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=2160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}